https://newsroom.viatris.com/ Newsroom https://newsroom.viatris.com/2026-04-13-Viatris-to-Report-First-Quarter-2026-Financial-Results-on-May-7,-2026 Mon, 13 Apr 2026 06:59:00 -0400 https://newsroom.viatris.com/2026-04-13-Viatris-to-Report-First-Quarter-2026-Financial-Results-on-May-7,-2026 https://newsroom.viatris.com/2026-04-10-Viatris-Announces-Multiple-Data-Presentations-at-the-2026-American-Society-of-Cataract-and-Refractive-Surgery-Annual-Meeting Fri, 10 Apr 2026 06:59:00 -0400 https://newsroom.viatris.com/2026-04-10-Viatris-Announces-Multiple-Data-Presentations-at-the-2026-American-Society-of-Cataract-and-Refractive-Surgery-Annual-Meeting https://newsroom.viatris.com/2026-03-23-Viatris-Advances-Innovative-Portfolio-with-Approval-of-Effexor-R-in-Japan-for-Adults-with-Generalized-Anxiety-Disorder-GAD Mon, 23 Mar 2026 06:59:00 -0400 https://newsroom.viatris.com/2026-03-23-Viatris-Advances-Innovative-Portfolio-with-Approval-of-Effexor-R-in-Japan-for-Adults-with-Generalized-Anxiety-Disorder-GAD https://newsroom.viatris.com/2026-03-19-Viatris-to-Outline-its-Vision-for-Sustained-Revenue-and-Earnings-Growth-Through-2030 Thu, 19 Mar 2026 08:30:00 -0400 https://newsroom.viatris.com/2026-03-19-Viatris-to-Outline-its-Vision-for-Sustained-Revenue-and-Earnings-Growth-Through-2030 https://newsroom.viatris.com/2026-02-26-Viatris-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results Thu, 26 Feb 2026 06:59:00 -0500 https://newsroom.viatris.com/2026-02-26-Viatris-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results https://newsroom.viatris.com/2026-02-26-Viatris-Maintains-Dividend-Policy-for-2026-and-Announces-Quarterly-Dividend Thu, 26 Feb 2026 06:55:00 -0500 https://newsroom.viatris.com/2026-02-26-Viatris-Maintains-Dividend-Policy-for-2026-and-Announces-Quarterly-Dividend https://newsroom.viatris.com/2026-02-25-FDA-Accepts-Viatris-Supplemental-New-Drug-Application-for-MR-141-Phentolamine-Ophthalmic-Solution-0-75-for-the-Treatment-of-Presbyopia Wed, 25 Feb 2026 06:59:00 -0500 https://newsroom.viatris.com/2026-02-25-FDA-Accepts-Viatris-Supplemental-New-Drug-Application-for-MR-141-Phentolamine-Ophthalmic-Solution-0-75-for-the-Treatment-of-Presbyopia https://newsroom.viatris.com/2026-02-03-Viatris-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-26,-2026,-and-Host-Investor-Event-on-March-19,-2026 Tue, 03 Feb 2026 16:34:00 -0500 https://newsroom.viatris.com/2026-02-03-Viatris-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-26,-2026,-and-Host-Investor-Event-on-March-19,-2026 https://newsroom.viatris.com/2026-02-03-Viatris-Appoints-Matthew-J-Maletta-as-Chief-Legal-Officer Tue, 03 Feb 2026 08:30:00 -0500 https://newsroom.viatris.com/2026-02-03-Viatris-Appoints-Matthew-J-Maletta-as-Chief-Legal-Officer https://newsroom.viatris.com/2026-01-20-Viatris-Expands-Innovative-Portfolio-in-Cardiovascular-Diseases-with-the-Companys-First-Launch-of-Inpefa-R-Sotagliflozin-for-the-Treatment-of-Heart-Failure Tue, 20 Jan 2026 06:59:00 -0500 https://newsroom.viatris.com/2026-01-20-Viatris-Expands-Innovative-Portfolio-in-Cardiovascular-Diseases-with-the-Companys-First-Launch-of-Inpefa-R-Sotagliflozin-for-the-Treatment-of-Heart-Failure https://newsroom.viatris.com/2026-01-08-Viatris-Appoints-Lara-Ramsburg-as-Chief-People-and-Corporate-Affairs-Officer Thu, 08 Jan 2026 09:05:00 -0500 https://newsroom.viatris.com/2026-01-08-Viatris-Appoints-Lara-Ramsburg-as-Chief-People-and-Corporate-Affairs-Officer https://newsroom.viatris.com/2025-12-18-Viatris-Provides-Pipeline-Update-on-Four-Regulatory-Milestones Thu, 18 Dec 2025 06:59:00 -0500 https://newsroom.viatris.com/2025-12-18-Viatris-Provides-Pipeline-Update-on-Four-Regulatory-Milestones https://newsroom.viatris.com/2025-12-17-Viatris-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference Wed, 17 Dec 2025 06:59:00 -0500 https://newsroom.viatris.com/2025-12-17-Viatris-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference https://newsroom.viatris.com/2025-12-06-Viatris-Announces-Agreement-to-Monetize-its-Equity-Stake-in-Biocon-Biologics-Limited Sat, 06 Dec 2025 09:00:00 -0500 https://newsroom.viatris.com/2025-12-06-Viatris-Announces-Agreement-to-Monetize-its-Equity-Stake-in-Biocon-Biologics-Limited https://newsroom.viatris.com/2025-11-24-Viatris-to-Participate-in-Upcoming-Investor-Conferences Mon, 24 Nov 2025 08:00:00 -0500 https://newsroom.viatris.com/2025-11-24-Viatris-to-Participate-in-Upcoming-Investor-Conferences